4//SEC Filing
TENAX THERAPEUTICS, INC. 4
Accession 0001654954-17-003111
$TENXCIK 0000034956operating
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 6:30 PM ET
Size
5.5 KB
Accession
0001654954-17-003111
Insider Transaction Report
Form 4
Jebsen Michael B
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2017-04-03+200,000→ 200,000 totalExercise: $0.53Exp: 2027-04-03→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable in four equal annual installments beginning on April 3, 2018, however, the vesting of the option will accelerate and become fully vested upon the achievement of specified performance goals.
Documents
Issuer
TENAX THERAPEUTICS, INC.
CIK 0000034956
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000034956
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 6:30 PM ET
- Size
- 5.5 KB